China Traditional Chinese Medicine Holdings Ausschüttungen und Rückkäufe
Zukünftiges Wachstum Kriterienprüfungen 0/6
China Traditional Chinese Medicine Holdings hat in der Vergangenheit keine Dividende gezahlt.
Wichtige Informationen
n/a
Dividendenausschüttung
n/a
Rückkaufsrendite
| Gesamte Aktionärsrendite | n/a |
| Zukünftige Dividendenrendite | 0% |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | HK$0.0516 |
| Ausschüttungsquote | 21% |
Jüngste Updates zu Dividenden und Rückkäufen
Recent updates
China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable
Jan 04
Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?
Oct 23Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Aug 23Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?
May 22China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year
Dec 08These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively
Sep 05China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially
Jul 20Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Jul 18Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock
Jun 01Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly
Apr 28Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Feb 14Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock
Jan 11Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly
Dec 05China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate
Oct 29I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease
Oct 11These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Reasonably Well
Aug 24Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?
Jul 13China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jun 25Does China Traditional Chinese Medicine Holdings (HKG:570) Deserve A Spot On Your Watchlist?
Apr 04Are Investors Undervaluing China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) By 30%?
Mar 15China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 22China Traditional Chinese Medicine Holdings (HKG:570) Shareholders Have Enjoyed A 19% Share Price Gain
Feb 01What Percentage Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Do Insiders Own?
Dec 18Is China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Trading At A 33% Discount?
Dec 03
Declining Stock and Decent Financials: Is The Market Wrong About China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)?
Nov 18Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von 570 in der Vergangenheit stabil war.
Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von 570 gestiegen sind.
Dividendenrendite im Vergleich zum Markt
| China Traditional Chinese Medicine Holdings Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (570) | n/a |
| Untere 25 % des Marktes (HK) | 3.3% |
| Markt Top 25 % (HK) | 8.1% |
| Branchendurchschnitt (Pharmaceuticals) | 3.8% |
| Analystenprognose (570) (bis zu 3 Jahre) | 0% |
Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von 570 im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von 570 im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: 570 zahlt keine nennenswerte Dividende für den Markt Hong Kong.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da 570 keine Ausschüttungen gemeldet hat.